The Top 25 Healthcare Investors of 2021

Share Article

GrowthCap is pleased to announce The Top 25 Healthcare Investors of 2021.

GrowthCap is pleased to announce The Top 25 Healthcare Investors of 2021. In our inaugural year for these awards, we wanted to bring forth and recognize not only the most experienced and talented investors in healthcare but also those that help advance innovation across the sector. Whether in healthcare software, healthcare services, medical technologies, biotechnology, the connected patient experience, or other areas, these accomplished individuals have demonstrated a deep commitment to healthcare and as a result have succeeded both from a business standpoint as well as in having significant societal impact.

This year’s awardees were nominated by their firms, portfolio companies, healthcare industry colleagues, and/or peers at other investment firms. Awardee selections and rankings were based on deal experience and track record, strategic and operational capabilities provided to portfolio companies, unique and differentiated attributes, as well as contributions to charitable work and overall industry advancement. Healthcare plays a crucial role in the quality of our lives, underpins all other business and economic activity, and ultimately determines the state of our world. Please join us in recognizing and celebrating the achievements of The Top 25 Healthcare Investors of 2021.

Todd Sisitsky (TPG Capital), Robbert Vorhoff (General Atlantic), Joshua Nelson (Thomas H. Lee Partners), Ram Jagannath (The Blackstone Group), Jeff Crisan (Silversmith Capital Partners), Jim Quagliaroli (Silversmith Capital Partners), Julian Harris (Deerfield Management), Mark Taber (Great Hill Partners), Rafael Cofiño (Great Hill Partners), Michal Preminger (Johnson & Johnson Innovation), Matt Emery (JMI Equity), Sureel Sheth (JMI Equity), Nader Naini (Frazier Healthcare Partners), Jeff Haywood (Spectrum Equity), Steve LeSieur (Spectrum Equity ), Nikhil Sachdev (Insight Partners), Scott Feldman (Susquehanna Growth Equity), David Bonita (OrbiMed), Ezra Mehlman (Health Enterprise Partners), Ryan Harris (Norwest Venture Partners), Barbara Dalton (Pfizer Venture Investments), Patrick Dunnigan (River Cities Capital Funds), Anja König (Novartis Venture Fund), Sam Brasch (Kaiser Permanente Ventures), and Sam Major (Susquehanna Growth Equity).

The full article can be read at https://growthcapadvisory.com/.

About GrowthCap

GrowthCap’s primary focus is to aid CEOs in better understanding and connecting with the universe of capital alternatives offered by institutional investors such as private equity firms, growth equity firms, venture capital and family offices. GrowthCap also aims to provide CEOs with insights into how other entrepreneurs and executives have succeeded in scaling their businesses. While emphasis has been on select sectors including business software, business services, healthcare and consumer products and services, GrowthCap is often involved in other segments of the broader economy.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

RJ Lumba
GrowthCap
+1 646-470-3188
Email >
Visit website